Plasma soluble interleukin-2-receptor in depression: relationships to plasma neopterin and serum IL-2 concentrations and HPA-axis activity

[1]  M. Maes,et al.  The monocyte-T-lymphocyte hypothesis of major depression , 1995, Psychoneuroendocrinology.

[2]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  P. Blockx,et al.  Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic–pituitary–adrenal axis in depression , 1994, Psychological Medicine.

[4]  M. Collins,et al.  Glucocorticoid Hormones Upregulate Interleukin 2 Receptor α Gene Expression , 1993 .

[5]  L. Träskman-bendz,et al.  Increased soluble interleukin‐2 receptor concentrations in suicide attempters , 1993, Acta psychiatrica Scandinavica.

[6]  I. Hickie,et al.  Impaired In Vivo Immune Responses in Patients with Melancholia , 1993, British Journal of Psychiatry.

[7]  G. Stalla,et al.  Glucocorticoids modulate soluble interleukin-2 receptor levels in vivo depending on the state of immune activation and the duration of glucocorticoid exposure. , 1993, Immunopharmacology.

[8]  G. Mellsop,et al.  Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia , 1992, Psychological Medicine.

[9]  E. Bosmans,et al.  Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining , 1992, Psychological Medicine.

[10]  R. Bechhofer,et al.  Serum CD25 Levels During Interleukin‐2 Therapy: Dose Dependence and Correlations with Clinical Toxicity and Lymphocyte Surface sCD25 Expression , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[11]  E. Bosmans,et al.  Depression‐related disturbances in mitogen‐induced lymphocyte responses and interleukin‐1β and soluble interleukin‐2 receptor production , 1991, Acta psychiatrica Scandinavica.

[12]  M. Maes,et al.  A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and β‐endorphin in melancholic patients , 1991, Acta psychiatrica Scandinavica.

[13]  C. Plata-salamán.  Immunoregulators in the nervous system , 1991, Neuroscience & Biobehavioral Reviews.

[14]  D. Nelson,et al.  Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. , 1991, The Journal of clinical investigation.

[15]  E. Bosmans,et al.  Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. , 1991, Journal of affective disorders.

[16]  E. Bosmans,et al.  Impaired Lymphocyte Stimulation by Mitogens in Severely Depressed Patients , 1989, British Journal of Psychiatry.

[17]  D. C. Howell.  Statistical Methods for Psychology , 1987 .

[18]  P. Nowell,et al.  Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. , 1986, Journal of immunology.

[19]  D. Fuchs,et al.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma , 1984, The Journal of experimental medicine.

[20]  S. Arya,et al.  Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. , 1984, Journal of immunology.

[21]  J. Davidson,et al.  Urinary excretion of bioterin and neopterin in psychiatric disorders , 1984, Psychiatry Research.

[22]  G. Crabtree,et al.  Glucocorticoid-Induced Inhibition of T Cell Growth Factor Production , 1979, The Journal of Immunology.

[23]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[24]  C. Caruso,et al.  Biological significance of soluble IL-2 receptor , 1993, Mediators of inflammation.

[25]  D. Fuchs,et al.  The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. , 1992, Critical reviews in clinical laboratory sciences.

[26]  E. Werner,et al.  Determination of neopterin in serum and urine. , 1987, Clinical chemistry.